Sil­ver­back dish­es out two pro­mo­tions in C-suite; Leg­end CEO post changes hands again

→ Ac­com­pa­ny­ing the news that they just scored an $85 mil­lion Se­ries C round, Lau­ra Shawver-led Sil­ver­back Ther­a­peu­tics has pro­mot­ed two ex­ecs, with Va­lerie Ode­gard adding pres­i­dent to her CSO du­ties and Nao­mi Hun­der mov­ing to CMO. A No­vo Nordisk alum, Ode­gard has been with the Seat­tle-based biotech since 2016 and the CSO the last 2 years. Be­fore Sil­ver­back, she was VP of re­search at Juno Ther­a­peu­tics.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.